Last $44.29 USD
Change Today -0.06 / -0.14%
Volume 680.5K
As of 8:04 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for novo-nordisk a/s-spons adr (NVO)

Year over year, Novo Nordisk A/S has been able to grow revenues from $13.0B USD to $13.9B USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 17.26% to 16.92%. This was a driver that led to a bottom line growth from $3.6B USD to $4.2B USD.
View Income Statement In Danish Krone
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
USD
Dec 31
2011
USD
Dec 31
2012
USD
Dec 31
2013
USD
4 Year
Trend
Revenues10,118.611,045.912,990.513,913.9
TOTAL REVENUES10,118.611,045.912,990.513,913.9
Cost of Goods Sold1,944.62,095.92,241.82,354.2
GROSS PROFIT8,174.08,950.010,748.811,559.7
Selling General & Admin Expenses, Total3,539.63,704.24,138.34,476.6
R&D Expenses1,598.61,603.01,814.21,953.4
Other Operating Expenses-109.4-82.2-110.9-113.5
OTHER OPERATING EXPENSES, TOTAL5,028.85,225.05,841.66,316.5
OPERATING INCOME3,145.23,725.04,907.15,243.3
Interest Expense-83.2-45.8-9.7-9.2
Interest and Investment Income39.145.620.811.8
NET INTEREST EXPENSE-44.1-0.211.22.7
Currency Exchange Gains (Loss)-330.3-53.6-254.6190.8
Other Non-Operating Income (Expenses)277.5-16.5-13.8-16.0
EBT, EXCLUDING UNUSUAL ITEMS3,048.33,654.84,649.95,420.7
Gain (Loss) on Sale of Investments-3.8-4.5-19.6-3.3
EBT, INCLUDING UNUSUAL ITEMS3,044.43,650.34,630.35,417.4
Income Tax Expense646.5803.81,062.01,224.5
Earnings from Continuing Operations2,398.02,846.53,568.24,192.9
NET INCOME2,398.02,846.53,568.24,192.9
NET INCOME TO COMMON INCLUDING EXTRA ITEMS2,398.02,846.53,568.24,192.9
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS2,398.02,846.53,568.24,192.9
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVO:US $44.29 USD -0.06

NVO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $67.36 USD +2.17
Biogen Idec Inc $303.55 USD +4.45
Bristol-Myers Squibb Co $58.80 USD +0.19
Eli Lilly & Co $67.36 USD +0.56
Reckitt Benckiser Group PLC 5,160 GBp -30.00
View Industry Companies
 

Industry Analysis

NVO

Industry Average

Valuation NVO Industry Range
Price/Earnings 26.5x
Price/Sales 7.9x
Price/Book 17.9x
Price/Cash Flow 21.2x
TEV/Sales 6.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO-NORDISK A/S-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.